Conducting Clinical Trials With Decentralized Elements September 2024

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/conducting-clinical-trials-decentralized-elements?utm_medium=email&utm_source=govdelivery This final guidance provides recommendations for sponsors, investigators, and other interested community members regarding the implementation of clinical trials with decentralized elements. Decentralized elements allow trial-related activities to occur remotely at locations convenient for trial participants.